nodes	percent_of_prediction	percent_of_DWPC	metapath
Maprotiline—CHRM2—type 1 diabetes mellitus	0.708	1	CbGaD
Maprotiline—HTR7—umbilical artery—type 1 diabetes mellitus	0.0187	0.256	CbGeAlD
Maprotiline—HTR2A—arteriole—type 1 diabetes mellitus	0.0067	0.0918	CbGeAlD
Maprotiline—ORM1—saliva—type 1 diabetes mellitus	0.00622	0.0853	CbGeAlD
Maprotiline—SLC6A2—autonomic nervous system—type 1 diabetes mellitus	0.00477	0.0654	CbGeAlD
Maprotiline—HTR7—autonomic nervous system—type 1 diabetes mellitus	0.0046	0.0631	CbGeAlD
Maprotiline—Depressed mood—Ramipril—type 1 diabetes mellitus	0.00458	0.0495	CcSEcCtD
Maprotiline—Sleep disturbance—Ramipril—type 1 diabetes mellitus	0.00365	0.0395	CcSEcCtD
Maprotiline—Inappropriate antidiuretic hormone secretion—Ramipril—type 1 diabetes mellitus	0.00352	0.0381	CcSEcCtD
Maprotiline—SLC6A3—nerve—type 1 diabetes mellitus	0.00333	0.0456	CbGeAlD
Maprotiline—HTR7—peripheral nervous system—type 1 diabetes mellitus	0.00332	0.0455	CbGeAlD
Maprotiline—Bone marrow depression—Ramipril—type 1 diabetes mellitus	0.00303	0.0328	CcSEcCtD
Maprotiline—HTR2A—autonomic nervous system—type 1 diabetes mellitus	0.00287	0.0393	CbGeAlD
Maprotiline—SLC6A2—nerve—type 1 diabetes mellitus	0.00269	0.0368	CbGeAlD
Maprotiline—HTR7—nerve—type 1 diabetes mellitus	0.00259	0.0355	CbGeAlD
Maprotiline—Endocrine disorder—Ramipril—type 1 diabetes mellitus	0.00247	0.0267	CcSEcCtD
Maprotiline—DRD2—nerve—type 1 diabetes mellitus	0.00245	0.0335	CbGeAlD
Maprotiline—HTR2A—peripheral nervous system—type 1 diabetes mellitus	0.00207	0.0284	CbGeAlD
Maprotiline—Salivary hypersecretion—Ramipril—type 1 diabetes mellitus	0.00199	0.0215	CcSEcCtD
Maprotiline—Gynaecomastia—Ramipril—type 1 diabetes mellitus	0.00183	0.0198	CcSEcCtD
Maprotiline—Sleep disorder—Ramipril—type 1 diabetes mellitus	0.00172	0.0185	CcSEcCtD
Maprotiline—Vascular purpura—Ramipril—type 1 diabetes mellitus	0.00166	0.0179	CcSEcCtD
Maprotiline—Nasal congestion—Ramipril—type 1 diabetes mellitus	0.00163	0.0176	CcSEcCtD
Maprotiline—HTR2A—nerve—type 1 diabetes mellitus	0.00161	0.0221	CbGeAlD
Maprotiline—Libido decreased—Ramipril—type 1 diabetes mellitus	0.0016	0.0173	CcSEcCtD
Maprotiline—Purpura—Ramipril—type 1 diabetes mellitus	0.00154	0.0167	CcSEcCtD
Maprotiline—Cerebrovascular accident—Ramipril—type 1 diabetes mellitus	0.00152	0.0164	CcSEcCtD
Maprotiline—Disturbance in sexual arousal—Ramipril—type 1 diabetes mellitus	0.00147	0.0159	CcSEcCtD
Maprotiline—Liver function test abnormal—Ramipril—type 1 diabetes mellitus	0.00137	0.0148	CcSEcCtD
Maprotiline—Orthostatic hypotension—Ramipril—type 1 diabetes mellitus	0.00136	0.0147	CcSEcCtD
Maprotiline—Breast disorder—Ramipril—type 1 diabetes mellitus	0.00134	0.0145	CcSEcCtD
Maprotiline—Toxic epidermal necrolysis—Ramipril—type 1 diabetes mellitus	0.00134	0.0145	CcSEcCtD
Maprotiline—Dysphagia—Ramipril—type 1 diabetes mellitus	0.00128	0.0139	CcSEcCtD
Maprotiline—Eosinophilia—Ramipril—type 1 diabetes mellitus	0.00127	0.0137	CcSEcCtD
Maprotiline—Bronchospasm—Ramipril—type 1 diabetes mellitus	0.00126	0.0136	CcSEcCtD
Maprotiline—Sweating increased—Ramipril—type 1 diabetes mellitus	0.00125	0.0135	CcSEcCtD
Maprotiline—Pancytopenia—Ramipril—type 1 diabetes mellitus	0.00122	0.0132	CcSEcCtD
Maprotiline—Metixene—CHRM2—type 1 diabetes mellitus	0.00121	0.353	CrCbGaD
Maprotiline—Erectile dysfunction—Ramipril—type 1 diabetes mellitus	0.00118	0.0128	CcSEcCtD
Maprotiline—Photosensitivity reaction—Ramipril—type 1 diabetes mellitus	0.00117	0.0127	CcSEcCtD
Maprotiline—CHRM2—cardiovascular system—type 1 diabetes mellitus	0.00117	0.016	CbGeAlD
Maprotiline—Weight increased—Ramipril—type 1 diabetes mellitus	0.00117	0.0126	CcSEcCtD
Maprotiline—Stevens-Johnson syndrome—Ramipril—type 1 diabetes mellitus	0.00114	0.0123	CcSEcCtD
Maprotiline—Acute coronary syndrome—Ramipril—type 1 diabetes mellitus	0.00113	0.0122	CcSEcCtD
Maprotiline—Neuropathy peripheral—Ramipril—type 1 diabetes mellitus	0.00112	0.0121	CcSEcCtD
Maprotiline—Myocardial infarction—Ramipril—type 1 diabetes mellitus	0.00112	0.0121	CcSEcCtD
Maprotiline—Stomatitis—Ramipril—type 1 diabetes mellitus	0.00112	0.0121	CcSEcCtD
Maprotiline—Jaundice—Ramipril—type 1 diabetes mellitus	0.00112	0.0121	CcSEcCtD
Maprotiline—Hepatobiliary disease—Ramipril—type 1 diabetes mellitus	0.00108	0.0117	CcSEcCtD
Maprotiline—Agranulocytosis—Ramipril—type 1 diabetes mellitus	0.00107	0.0115	CcSEcCtD
Maprotiline—CHRM1—cardiovascular system—type 1 diabetes mellitus	0.00106	0.0146	CbGeAlD
Maprotiline—Hepatitis—Ramipril—type 1 diabetes mellitus	0.00103	0.0111	CcSEcCtD
Maprotiline—DRD2—retina—type 1 diabetes mellitus	0.00101	0.0139	CbGeAlD
Maprotiline—Erythema multiforme—Ramipril—type 1 diabetes mellitus	0.000972	0.0105	CcSEcCtD
Maprotiline—Tinnitus—Ramipril—type 1 diabetes mellitus	0.000958	0.0104	CcSEcCtD
Maprotiline—Flushing—Ramipril—type 1 diabetes mellitus	0.000954	0.0103	CcSEcCtD
Maprotiline—CHRM3—kidney—type 1 diabetes mellitus	0.000932	0.0128	CbGeAlD
Maprotiline—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.000926	0.01	CcSEcCtD
Maprotiline—Arrhythmia—Ramipril—type 1 diabetes mellitus	0.000918	0.00992	CcSEcCtD
Maprotiline—Alopecia—Ramipril—type 1 diabetes mellitus	0.000908	0.00981	CcSEcCtD
Maprotiline—HTR7—cardiovascular system—type 1 diabetes mellitus	0.000907	0.0124	CbGeAlD
Maprotiline—Malnutrition—Ramipril—type 1 diabetes mellitus	0.000895	0.00967	CcSEcCtD
Maprotiline—HTR7—kidney—type 1 diabetes mellitus	0.000887	0.0122	CbGeAlD
Maprotiline—Tension—Ramipril—type 1 diabetes mellitus	0.000878	0.00949	CcSEcCtD
Maprotiline—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.000876	0.00947	CcSEcCtD
Maprotiline—Nervousness—Ramipril—type 1 diabetes mellitus	0.000869	0.00939	CcSEcCtD
Maprotiline—Tremor—Ramipril—type 1 diabetes mellitus	0.000838	0.00906	CcSEcCtD
Maprotiline—Agitation—Ramipril—type 1 diabetes mellitus	0.000822	0.00889	CcSEcCtD
Maprotiline—Syncope—Ramipril—type 1 diabetes mellitus	0.000802	0.00867	CcSEcCtD
Maprotiline—Leukopenia—Ramipril—type 1 diabetes mellitus	0.000801	0.00865	CcSEcCtD
Maprotiline—Palpitations—Ramipril—type 1 diabetes mellitus	0.000791	0.00854	CcSEcCtD
Maprotiline—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.000786	0.0085	CcSEcCtD
Maprotiline—Convulsion—Ramipril—type 1 diabetes mellitus	0.000775	0.00838	CcSEcCtD
Maprotiline—Anxiety—Ramipril—type 1 diabetes mellitus	0.000759	0.0082	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.000757	0.00817	CcSEcCtD
Maprotiline—Dry mouth—Ramipril—type 1 diabetes mellitus	0.000745	0.00805	CcSEcCtD
Maprotiline—Confusional state—Ramipril—type 1 diabetes mellitus	0.000736	0.00796	CcSEcCtD
Maprotiline—Oedema—Ramipril—type 1 diabetes mellitus	0.00073	0.00789	CcSEcCtD
Maprotiline—Shock—Ramipril—type 1 diabetes mellitus	0.000719	0.00776	CcSEcCtD
Maprotiline—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.000716	0.00774	CcSEcCtD
Maprotiline—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.000715	0.00773	CcSEcCtD
Maprotiline—Tachycardia—Ramipril—type 1 diabetes mellitus	0.000713	0.0077	CcSEcCtD
Maprotiline—Skin disorder—Ramipril—type 1 diabetes mellitus	0.000709	0.00766	CcSEcCtD
Maprotiline—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.000706	0.00763	CcSEcCtD
Maprotiline—Hypotension—Ramipril—type 1 diabetes mellitus	0.000682	0.00737	CcSEcCtD
Maprotiline—HTR2A—retina—type 1 diabetes mellitus	0.000668	0.00916	CbGeAlD
Maprotiline—Insomnia—Ramipril—type 1 diabetes mellitus	0.000661	0.00714	CcSEcCtD
Maprotiline—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.000656	0.00709	CcSEcCtD
Maprotiline—Somnolence—Ramipril—type 1 diabetes mellitus	0.000649	0.00702	CcSEcCtD
Maprotiline—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.000643	0.00695	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.000631	0.00681	CcSEcCtD
Maprotiline—Fatigue—Ramipril—type 1 diabetes mellitus	0.00063	0.0068	CcSEcCtD
Maprotiline—Constipation—Ramipril—type 1 diabetes mellitus	0.000625	0.00675	CcSEcCtD
Maprotiline—Nortriptyline—CHRM2—type 1 diabetes mellitus	0.000623	0.181	CrCbGaD
Maprotiline—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.000602	0.0065	CcSEcCtD
Maprotiline—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.000597	0.00645	CcSEcCtD
Maprotiline—Urticaria—Ramipril—type 1 diabetes mellitus	0.00058	0.00627	CcSEcCtD
Maprotiline—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.000577	0.00624	CcSEcCtD
Maprotiline—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.000577	0.00624	CcSEcCtD
Maprotiline—HTR2A—cardiovascular system—type 1 diabetes mellitus	0.000565	0.00775	CbGeAlD
Maprotiline—HTR2A—kidney—type 1 diabetes mellitus	0.000553	0.00758	CbGeAlD
Maprotiline—Asthenia—Ramipril—type 1 diabetes mellitus	0.000524	0.00566	CcSEcCtD
Maprotiline—Pruritus—Ramipril—type 1 diabetes mellitus	0.000517	0.00558	CcSEcCtD
Maprotiline—Desipramine—CHRM2—type 1 diabetes mellitus	0.000513	0.149	CrCbGaD
Maprotiline—ABCB1—islet of Langerhans—type 1 diabetes mellitus	0.000512	0.00702	CbGeAlD
Maprotiline—CYP2D6—kidney—type 1 diabetes mellitus	0.000504	0.00691	CbGeAlD
Maprotiline—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.0005	0.0054	CcSEcCtD
Maprotiline—Dizziness—Ramipril—type 1 diabetes mellitus	0.000483	0.00522	CcSEcCtD
Maprotiline—Vomiting—Ramipril—type 1 diabetes mellitus	0.000464	0.00502	CcSEcCtD
Maprotiline—Rash—Ramipril—type 1 diabetes mellitus	0.00046	0.00498	CcSEcCtD
Maprotiline—Dermatitis—Ramipril—type 1 diabetes mellitus	0.00046	0.00497	CcSEcCtD
Maprotiline—Headache—Ramipril—type 1 diabetes mellitus	0.000458	0.00494	CcSEcCtD
Maprotiline—ABCB1—retina—type 1 diabetes mellitus	0.000438	0.006	CbGeAlD
Maprotiline—Desipramine—ADRB1—type 1 diabetes mellitus	0.000437	0.127	CrCbGaD
Maprotiline—Imipramine—CHRM2—type 1 diabetes mellitus	0.000435	0.127	CrCbGaD
Maprotiline—Nausea—Ramipril—type 1 diabetes mellitus	0.000434	0.00469	CcSEcCtD
Maprotiline—ABCB1—nephron tubule—type 1 diabetes mellitus	0.000412	0.00565	CbGeAlD
Maprotiline—ABCB1—cardiovascular system—type 1 diabetes mellitus	0.00037	0.00508	CbGeAlD
Maprotiline—ABCB1—kidney—type 1 diabetes mellitus	0.000362	0.00497	CbGeAlD
Maprotiline—ABCB1—pancreas—type 1 diabetes mellitus	0.00036	0.00494	CbGeAlD
Maprotiline—ABCB1—lymphoid tissue—type 1 diabetes mellitus	0.000311	0.00427	CbGeAlD
Maprotiline—Nortriptyline—ALB—type 1 diabetes mellitus	0.000213	0.0621	CrCbGaD
Maprotiline—HTR2C—Signaling Pathways—VAV1—type 1 diabetes mellitus	1.71e-05	0.000139	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CXCL10—type 1 diabetes mellitus	1.71e-05	0.000138	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.7e-05	0.000137	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.67e-05	0.000135	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.66e-05	0.000134	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.65e-05	0.000134	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—ITPR3—type 1 diabetes mellitus	1.63e-05	0.000132	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.62e-05	0.000131	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—GCG—type 1 diabetes mellitus	1.62e-05	0.000131	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.6e-05	0.00013	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—CAT—type 1 diabetes mellitus	1.6e-05	0.000129	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—GCG—type 1 diabetes mellitus	1.59e-05	0.000129	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.59e-05	0.000129	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—GCG—type 1 diabetes mellitus	1.59e-05	0.000128	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—GCG—type 1 diabetes mellitus	1.58e-05	0.000128	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—GCG—type 1 diabetes mellitus	1.58e-05	0.000128	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—GCG—type 1 diabetes mellitus	1.56e-05	0.000126	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—TYK2—type 1 diabetes mellitus	1.56e-05	0.000126	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	1.56e-05	0.000126	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.55e-05	0.000126	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—KCNJ11—type 1 diabetes mellitus	1.55e-05	0.000125	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—ITPR3—type 1 diabetes mellitus	1.54e-05	0.000125	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—HBA1—type 1 diabetes mellitus	1.54e-05	0.000125	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	1.53e-05	0.000124	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—APOC3—type 1 diabetes mellitus	1.53e-05	0.000124	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	1.53e-05	0.000124	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	1.52e-05	0.000123	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	1.52e-05	0.000123	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—VAV1—type 1 diabetes mellitus	1.51e-05	0.000122	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CXCL10—type 1 diabetes mellitus	1.51e-05	0.000122	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	1.5e-05	0.000122	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—GSTT1—type 1 diabetes mellitus	1.5e-05	0.000122	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CD86—type 1 diabetes mellitus	1.49e-05	0.000121	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—VAV1—type 1 diabetes mellitus	1.49e-05	0.00012	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—VAV1—type 1 diabetes mellitus	1.48e-05	0.00012	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	1.48e-05	0.00012	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	1.48e-05	0.00012	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—VAV1—type 1 diabetes mellitus	1.48e-05	0.00012	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—CD80—type 1 diabetes mellitus	1.48e-05	0.00012	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	1.47e-05	0.000119	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—VAV1—type 1 diabetes mellitus	1.47e-05	0.000119	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CXCL10—type 1 diabetes mellitus	1.47e-05	0.000119	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—VAV1—type 1 diabetes mellitus	1.46e-05	0.000118	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CXCL10—type 1 diabetes mellitus	1.46e-05	0.000118	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—HBA1—type 1 diabetes mellitus	1.45e-05	0.000117	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—APOC3—type 1 diabetes mellitus	1.44e-05	0.000117	CbGpPWpGaD
Maprotiline—HTR2C—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.43e-05	0.000115	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.42e-05	0.000115	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—GSTT1—type 1 diabetes mellitus	1.41e-05	0.000115	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—INS—type 1 diabetes mellitus	1.4e-05	0.000113	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—CD80—type 1 diabetes mellitus	1.39e-05	0.000113	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—TYK2—type 1 diabetes mellitus	1.37e-05	0.000111	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.37e-05	0.000111	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	1.35e-05	0.000109	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.35e-05	0.000109	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	1.35e-05	0.000109	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.35e-05	0.000109	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.35e-05	0.000109	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	1.34e-05	0.000109	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.34e-05	0.000109	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.34e-05	0.000109	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—TYK2—type 1 diabetes mellitus	1.34e-05	0.000108	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.34e-05	0.000108	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—CD80—type 1 diabetes mellitus	1.34e-05	0.000108	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.33e-05	0.000108	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—TYK2—type 1 diabetes mellitus	1.33e-05	0.000107	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.32e-05	0.000107	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.32e-05	0.000107	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—INS—type 1 diabetes mellitus	1.32e-05	0.000107	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CD86—type 1 diabetes mellitus	1.32e-05	0.000107	CbGpPWpGaD
Maprotiline—ABCB1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	1.32e-05	0.000107	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—ITPR3—type 1 diabetes mellitus	1.3e-05	0.000106	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.3e-05	0.000106	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CD86—type 1 diabetes mellitus	1.3e-05	0.000105	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.29e-05	0.000105	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CD86—type 1 diabetes mellitus	1.29e-05	0.000105	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CD86—type 1 diabetes mellitus	1.29e-05	0.000104	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CD86—type 1 diabetes mellitus	1.28e-05	0.000104	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.27e-05	0.000103	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CD86—type 1 diabetes mellitus	1.27e-05	0.000103	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.27e-05	0.000103	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—INS—type 1 diabetes mellitus	1.26e-05	0.000102	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.26e-05	0.000102	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.25e-05	0.000101	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.25e-05	0.000101	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.24e-05	0.0001	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.24e-05	0.0001	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.23e-05	9.97e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.23e-05	9.96e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—HBA1—type 1 diabetes mellitus	1.23e-05	9.94e-05	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.23e-05	9.94e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.23e-05	9.94e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.22e-05	9.91e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.22e-05	9.91e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.22e-05	9.89e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—APOC3—type 1 diabetes mellitus	1.22e-05	9.88e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.22e-05	9.87e-05	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.22e-05	9.84e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.21e-05	9.84e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.21e-05	9.78e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—GSTT1—type 1 diabetes mellitus	1.2e-05	9.71e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—GCG—type 1 diabetes mellitus	1.2e-05	9.69e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.19e-05	9.62e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.18e-05	9.53e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.17e-05	9.46e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.17e-05	9.46e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.17e-05	9.44e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.16e-05	9.41e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.16e-05	9.38e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.16e-05	9.36e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.15e-05	9.32e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.15e-05	9.31e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.15e-05	9.29e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.15e-05	9.29e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.14e-05	9.26e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.14e-05	9.25e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.14e-05	9.23e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.13e-05	9.17e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.13e-05	9.15e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.13e-05	9.14e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.13e-05	9.13e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—GCG—type 1 diabetes mellitus	1.13e-05	9.13e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.13e-05	9.12e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.12e-05	9.1e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.12e-05	9.1e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.12e-05	9.08e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.12e-05	9.06e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.11e-05	9.03e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.11e-05	9.01e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.11e-05	8.96e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	1.1e-05	8.94e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.1e-05	8.94e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CD80—type 1 diabetes mellitus	1.09e-05	8.82e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—INS—type 1 diabetes mellitus	1.06e-05	8.58e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.04e-05	8.41e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—IL2—type 1 diabetes mellitus	1.04e-05	8.4e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—IL6—type 1 diabetes mellitus	1.03e-05	8.36e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—INS—type 1 diabetes mellitus	1.03e-05	8.33e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—CAT—type 1 diabetes mellitus	1.01e-05	8.2e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—IGF1—type 1 diabetes mellitus	9.95e-06	8.06e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—EGFR—type 1 diabetes mellitus	9.9e-06	8.02e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—CASP3—type 1 diabetes mellitus	9.81e-06	7.95e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—IL2—type 1 diabetes mellitus	9.8e-06	7.93e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—IL6—type 1 diabetes mellitus	9.75e-06	7.89e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—ALB—type 1 diabetes mellitus	9.71e-06	7.86e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CD80—type 1 diabetes mellitus	9.61e-06	7.78e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—GCG—type 1 diabetes mellitus	9.55e-06	7.73e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—CAT—type 1 diabetes mellitus	9.54e-06	7.73e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CD80—type 1 diabetes mellitus	9.45e-06	7.66e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CD80—type 1 diabetes mellitus	9.43e-06	7.64e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CD80—type 1 diabetes mellitus	9.4e-06	7.62e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—CASP3—type 1 diabetes mellitus	9.39e-06	7.61e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—IL2—type 1 diabetes mellitus	9.38e-06	7.6e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CD80—type 1 diabetes mellitus	9.37e-06	7.59e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—IL6—type 1 diabetes mellitus	9.33e-06	7.56e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—NOS3—type 1 diabetes mellitus	9.29e-06	7.52e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CD80—type 1 diabetes mellitus	9.28e-06	7.52e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—TYK2—type 1 diabetes mellitus	9.19e-06	7.44e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—INS—type 1 diabetes mellitus	9.08e-06	7.35e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—NOS3—type 1 diabetes mellitus	9.02e-06	7.31e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—INS—type 1 diabetes mellitus	8.93e-06	7.23e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—INS—type 1 diabetes mellitus	8.91e-06	7.22e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—INS—type 1 diabetes mellitus	8.88e-06	7.2e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—INS—type 1 diabetes mellitus	8.86e-06	7.17e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—IGF1—type 1 diabetes mellitus	8.78e-06	7.11e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—INS—type 1 diabetes mellitus	8.77e-06	7.1e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	8.74e-06	7.08e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—STAT3—type 1 diabetes mellitus	8.73e-06	7.07e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—IGF1—type 1 diabetes mellitus	8.64e-06	7e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—IGF1—type 1 diabetes mellitus	8.62e-06	6.98e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	8.6e-06	6.96e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—IGF1—type 1 diabetes mellitus	8.59e-06	6.96e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	8.58e-06	6.95e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—IGF1—type 1 diabetes mellitus	8.57e-06	6.94e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	8.55e-06	6.93e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—EGFR—type 1 diabetes mellitus	8.52e-06	6.9e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—IGF1—type 1 diabetes mellitus	8.48e-06	6.87e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	8.44e-06	6.84e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—STAT3—type 1 diabetes mellitus	8.24e-06	6.68e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—TYK2—type 1 diabetes mellitus	8.11e-06	6.57e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—CAT—type 1 diabetes mellitus	8.08e-06	6.55e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—TYK2—type 1 diabetes mellitus	7.98e-06	6.46e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—TYK2—type 1 diabetes mellitus	7.96e-06	6.45e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—NOS3—type 1 diabetes mellitus	7.96e-06	6.45e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—TYK2—type 1 diabetes mellitus	7.94e-06	6.43e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—EGFR—type 1 diabetes mellitus	7.93e-06	6.43e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—TYK2—type 1 diabetes mellitus	7.91e-06	6.41e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—STAT3—type 1 diabetes mellitus	7.89e-06	6.39e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—TYK2—type 1 diabetes mellitus	7.84e-06	6.35e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—NOS3—type 1 diabetes mellitus	7.83e-06	6.34e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—NOS3—type 1 diabetes mellitus	7.82e-06	6.33e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—NOS3—type 1 diabetes mellitus	7.79e-06	6.31e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—NOS3—type 1 diabetes mellitus	7.77e-06	6.29e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—NOS3—type 1 diabetes mellitus	7.69e-06	6.23e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CASP3—type 1 diabetes mellitus	7.66e-06	6.2e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—IL2—type 1 diabetes mellitus	7.65e-06	6.19e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—IL6—type 1 diabetes mellitus	7.61e-06	6.16e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—EGFR—type 1 diabetes mellitus	7.49e-06	6.07e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—EGFR—type 1 diabetes mellitus	7.17e-06	5.81e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.76e-06	5.47e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—IL2—type 1 diabetes mellitus	6.75e-06	5.47e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—INS—type 1 diabetes mellitus	6.72e-06	5.44e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—IL6—type 1 diabetes mellitus	6.72e-06	5.44e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.65e-06	5.39e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—IL2—type 1 diabetes mellitus	6.64e-06	5.38e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.64e-06	5.37e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—IL2—type 1 diabetes mellitus	6.63e-06	5.37e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.61e-06	5.36e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—IL6—type 1 diabetes mellitus	6.61e-06	5.35e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—IL2—type 1 diabetes mellitus	6.6e-06	5.35e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.59e-06	5.34e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—IL6—type 1 diabetes mellitus	6.59e-06	5.34e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—IL2—type 1 diabetes mellitus	6.58e-06	5.33e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—IL6—type 1 diabetes mellitus	6.57e-06	5.32e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—IL6—type 1 diabetes mellitus	6.55e-06	5.31e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.53e-06	5.29e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—IL2—type 1 diabetes mellitus	6.52e-06	5.28e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—IL6—type 1 diabetes mellitus	6.49e-06	5.25e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.43e-06	5.21e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—INS—type 1 diabetes mellitus	6.33e-06	5.13e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—ALB—type 1 diabetes mellitus	6.16e-06	4.99e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—IL6—type 1 diabetes mellitus	6.1e-06	4.94e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—NOS3—type 1 diabetes mellitus	5.89e-06	4.77e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.85e-06	4.74e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—ALB—type 1 diabetes mellitus	5.81e-06	4.7e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—IL6—type 1 diabetes mellitus	5.76e-06	4.66e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.68e-06	4.6e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.59e-06	4.53e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.58e-06	4.52e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.56e-06	4.5e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—NOS3—type 1 diabetes mellitus	5.55e-06	4.5e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.54e-06	4.49e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—IL6—type 1 diabetes mellitus	5.51e-06	4.47e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.49e-06	4.44e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—INS—type 1 diabetes mellitus	5.37e-06	4.35e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.16e-06	4.18e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.08e-06	4.11e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.07e-06	4.1e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.05e-06	4.09e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.04e-06	4.08e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.99e-06	4.04e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—ALB—type 1 diabetes mellitus	4.92e-06	3.98e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—NOS3—type 1 diabetes mellitus	4.7e-06	3.81e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—IL6—type 1 diabetes mellitus	4.49e-06	3.64e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—IL6—type 1 diabetes mellitus	3.97e-06	3.21e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—IL6—type 1 diabetes mellitus	3.9e-06	3.16e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—IL6—type 1 diabetes mellitus	3.89e-06	3.15e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—IL6—type 1 diabetes mellitus	3.88e-06	3.14e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—IL6—type 1 diabetes mellitus	3.87e-06	3.13e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—IL6—type 1 diabetes mellitus	3.83e-06	3.1e-05	CbGpPWpGaD
